ICD-10 category · Morphology of neoplasms · M975
M975 Neoplasms of histiocytes and accessory lymphoid cells
19 codes under M975 in the South African Master Industry Table 2021, 19 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M9750/3 | Malignant histiocytosis, primary site | Valid · not as primary | — |
| M9750/6 | Malignant histiocytosis, metastatic site | Valid · not as primary | — |
| M9751/1 | Langerhans cell histiocytosis, NOS, uncertain whether benign or malignant | Valid · not as primary | — |
| M9751/3 | Langerhans cell histiocytosis, NOS, malignant, primary site | Valid · not as primary | — |
| M9751/6 | Langerhans cell histiocytosis, NOS, malignant, metastatic site | Valid · not as primary | — |
| M9752/1 | Langerhans cell histiocytosis, unifocal, uncertain whether benign or malignant | Valid · not as primary | — |
| M9753/1 | Langerhans cell histiocytosis, multifocal, uncertain whether benign or malignant | Valid · not as primary | — |
| M9754/3 | Langerhans cell histiocytosis, disseminated, malignant, primary site | Valid · not as primary | — |
| M9754/6 | Langerhans cell histiocytosis, disseminated, malignant, metastatic site | Valid · not as primary | — |
| M9755/3 | Histiocytic sarcoma, malignant, primary site | Valid · not as primary | — |
| M9755/6 | Histiocytic sarcoma, malignant, metastatic site | Valid · not as primary | — |
| M9756/3 | Langerhans cell sarcoma, malignant, primary site | Valid · not as primary | — |
| M9756/6 | Langerhans cell sarcoma, malignant, metastatic site | Valid · not as primary | — |
| M9757/3 | Interdigitating dendritic cell sarcoma, malignant, primary site | Valid · not as primary | — |
| M9757/6 | Interdigitating dendritic cell sarcoma, malignant, metastatic site | Valid · not as primary | — |
| M9758/3 | Follicular dendritic cell sarcoma, malignant, primary site | Valid · not as primary | — |
| M9758/6 | Follicular dendritic cell sarcoma, malignant, metastatic site | Valid · not as primary | — |
| M9759/3 | Fibroblastic reticular cell tumour, malignant, primary site | Valid · not as primary | — |
| M9759/6 | Fibroblastic reticular cell tumour, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.